Search research articles
Contact Us
Filters
Showing results (151-160 of 471) with videos related to
Page
of 48
Sort By:
European Journal of Heart Failure
|
August 9, 2005
The relevance of comorbidities for heart failure treatment in primary care: A European survey
Heidrun B Sturm, Flora M Haaijer-Ruskamp, Nic J Veeger, et al.
European Journal of Heart Failure
|
November 4, 2009
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008
Dirk J van Veldhuisen, Alexander H Maass, Silvia G Priori, et al.
European Journal of Heart Failure
|
April 24, 2023
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction
Michael Böhm, Amr Abdin, Jonathan Slawik, et al.
The American Journal of Cardiology
|
October 29, 2015
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)
Michael Böhm, Michele Robertson, Ian Ford, et al.
International Journal of Cardiology
|
April 29, 2015
Person-centred care after acute coronary syndrome, from hospital to primary care - A randomised controlled trial
Andreas Fors, Inger Ekman, Charles Taft, et al.
Current Heart Failure Reports
|
April 11, 2025
Person-Centred Care: State-of-the-Art and Future Perspectives
Hanna Gyllensten, Matilda Cederberg, Sara Alsén, et al.
European Heart Journal
|
March 16, 2005
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET
Karl Swedberg, Lars G Olsson, Andrew Charlesworth, et al.
European Heart Journal
|
November 4, 2004
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
Eileen O'Meara, Scott Solomon, John McMurray, et al.
JACC. Heart Failure
|
March 5, 2018
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure
Muthiah Vaduganathan, Brian Claggett, Milton Packer, et al.
Cardiology
|
September 12, 2016
Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris
Jeffrey S Borer, Karl Swedberg, Michel Komajda, et al.
Page
of 48
Search research articles
Search
Showing results (151-160 of 471) with videos related to
Sort By:
Page
of 48
European Journal of Heart Failure
|
August 9, 2005
The relevance of comorbidities for heart failure treatment in primary care: A European survey
Heidrun B Sturm, Flora M Haaijer-Ruskamp, Nic J Veeger, et al.
European Journal of Heart Failure
|
November 4, 2009
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008
Dirk J van Veldhuisen, Alexander H Maass, Silvia G Priori, et al.
European Journal of Heart Failure
|
April 24, 2023
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction
Michael Böhm, Amr Abdin, Jonathan Slawik, et al.
The American Journal of Cardiology
|
October 29, 2015
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)
Michael Böhm, Michele Robertson, Ian Ford, et al.
International Journal of Cardiology
|
April 29, 2015
Person-centred care after acute coronary syndrome, from hospital to primary care - A randomised controlled trial
Andreas Fors, Inger Ekman, Charles Taft, et al.
Current Heart Failure Reports
|
April 11, 2025
Person-Centred Care: State-of-the-Art and Future Perspectives
Hanna Gyllensten, Matilda Cederberg, Sara Alsén, et al.
European Heart Journal
|
March 16, 2005
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET
Karl Swedberg, Lars G Olsson, Andrew Charlesworth, et al.
European Heart Journal
|
November 4, 2004
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
Eileen O'Meara, Scott Solomon, John McMurray, et al.
JACC. Heart Failure
|
March 5, 2018
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure
Muthiah Vaduganathan, Brian Claggett, Milton Packer, et al.
Cardiology
|
September 12, 2016
Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris
Jeffrey S Borer, Karl Swedberg, Michel Komajda, et al.
Page
of 48